Skip to main content
 

Kelvin Health

Kelvin Health

We believe that there is a unique opportunity to help hundreds of millions of patients and their families, thanks to our expertise in machine learning, the creation of a unique dataset with our R&D partners, and taking advantage of the continuously growing trend towards personalized healthcare and telemedicine.

 Start the conversation: [email protected]       Clinical pilots / feasibility studies      Validation or real-world evidence                                    Advisory input from clinicians or scientists        Research collaboration     Professional science or education collaboration                             Quality improvement initiatives

More News

  • Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

  • AccurKardia receives patent for AI-ECG cardiac amyloidosis detection

  • Rewriting Early Detection: How AI Is Redefining Cardiovascular Diagnostics